Summary of Significant Accounting Policies - Schedule of Research and Development Expenses (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2026	Mar. 31, 2025
Restricted Cash and Cash Equivalent Item [Line Items]
Total research and development	[1]	$ 39,802	$ 20,635
Research And Development Trials And Consumables Expense [Member]
Restricted Cash and Cash Equivalent Item [Line Items]
Total research and development		28,848	13,278
Payroll And Personnel Expenses [Member]
Restricted Cash and Cash Equivalent Item [Line Items]
Total research and development		9,455	5,561
Facilities And Other Expenses [Member]
Restricted Cash and Cash Equivalent Item [Line Items]
Total research and development		$ 1,499	$ 1,796

[1] Research and development expenses include related party amounts of $142 and $264 for the three months ended March 31, 2026 and 2025, respectively.